{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:49:45Z","timestamp":1789051785446,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background and Aims<\/jats:title>\n            <jats:p>Obesity is a well-established risk factor for gallstone formation, but traditional anthropometric measures (e.g., BMI, waist circumference) inadequately assess metabolically active visceral adiposity. The novel Metabolic Score for Visceral Fat (METS-VF) may better capture obesity-related metabolic dysfunction. We aimed to investigate the association between METS-VF and gallstone prevalence and compare its predictive performance against conventional obesity indices (WC, LAP, VAI) in a U.S. national cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This cross-sectional study analyzed nationally representative data from 3,010 US adults in NHANES 2017\u20132020 (aged 20\u201385 years, 51.3% male, multi-ethnic population). We employed weighted multivariable logistic regression to examine the METS-VF-gallstones association, with restricted cubic splines testing nonlinearity. Predictive performance of METS-VF versus traditional indices (WC\/LAP\/VAI) was compared using ROC curves and XGBoost machine learning.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 3,010 U.S. adults (mean age 47.8\u2009\u00b1\u200917.0 years, 51.3% male) in the NHANES 2017\u20132020 cohort, multivariable analysis revealed METS-VF as the strongest independent predictor of gallstones (adjusted OR\u2009=\u20092.02, 95%CI:1.20\u20133.40). Notably, METS-VF demonstrated significantly superior discriminative ability with the highest AUC of 0.712 (95%CI:0.684\u20130.739) compared to conventional indices (WC:0.635, LAP:0.609, VAI:0.530; all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The cross-sectional analysis demonstrates a significant association between METS-VF and gallstone prevalence (OR\u2009=\u20092.02, 95% CI:1.20\u20133.40), with relatively better predictive performance compared to conventional adiposity indices (AUC\u2009=\u20090.712). Its simple calculation using routine clinical measurements makes it ideally suited for implementation in primary care screening programs targeting high-risk populations with visceral adiposity. While these findings position METS-VF as a promising screening marker, its etiological role requires verification through longitudinal studies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12876-025-04161-x","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T13:50:30Z","timestamp":1753969830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["METS-VF as a novel predictor of gallstones in U.S. adults: a cross-sectional analysis (NHANES 2017\u20132020)"],"prefix":"10.1186","volume":"25","author":[{"given":"Hui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heshan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"issue":"6","key":"4161_CR1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.bpg.2006.05.004","volume":"20","author":"EA Shaffer","year":"2006","unstructured":"Shaffer EA. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol. 2006;20(6):981\u201396. https:\/\/doi.org\/10.1016\/j.bpg.2006.05.004.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"4161_CR2","doi-asserted-by":"publisher","first-page":"16024","DOI":"10.1038\/nrdp.2016.24","volume":"2","author":"F Lammert","year":"2016","unstructured":"Lammert F, Gurusamy K, Ko CW, et al. Gallstones Nat Rev Dis Primers. 2016;2:16024. https:\/\/doi.org\/10.1038\/nrdp.2016.24.","journal-title":"Gallstones Nat Rev Dis Primers"},{"issue":"2","key":"4161_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5009\/gnl.2012.6.2.172","volume":"6","author":"LM Stinton","year":"2012","unstructured":"Stinton LM, Shaffer EA. Epidemiology of gallbladder disease. Gut Liver. 2012;6(2):172\u201387. https:\/\/doi.org\/10.5009\/gnl.2012.6.2.172.","journal-title":"Gut Liver"},{"issue":"1","key":"4161_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jhep.2016.03.005","volume":"65","author":"European Association for the Study of the Liver (EASL)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL). EASL clinical practice guidelines on gallstones. J Hepatol. 2016;65(1):146\u201381. https:\/\/doi.org\/10.1016\/j.jhep.2016.03.005.","journal-title":"J Hepatol"},{"issue":"1","key":"4161_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12967-019-1919-y","volume":"17","author":"AD Lorenzo","year":"2019","unstructured":"Lorenzo AD, Gratteri S, Gualtieri P, et al. Why primary obesity is a disease? J Transl Med. 2019;17(1):169. https:\/\/doi.org\/10.1186\/s12967-019-1919-y.","journal-title":"J Transl Med"},{"key":"4161_CR6","doi-asserted-by":"publisher","first-page":"1276465","DOI":"10.3389\/fendo.2023.1276465","volume":"14","author":"B Ke","year":"2023","unstructured":"Ke B, Sun Y, Dai X, et al. Weight-adjusted waist circumference index and gallstones in NHANES 2017\u20132020. Front Endocrinol. 2023;14:1276465. https:\/\/doi.org\/10.3389\/fendo.2023.1276465.","journal-title":"Front Endocrinol"},{"key":"4161_CR7","doi-asserted-by":"publisher","first-page":"1025854","DOI":"10.3389\/fendo.2022.1025854","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Yang J, Chen Y, et al. METS-IR index and gallbladder stones. Front Endocrinol (Lausanne). 2022;13:1025854. https:\/\/doi.org\/10.3389\/fendo.2022.1025854.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"4161_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/MOG.0000000000000511","volume":"35","author":"SN Weber","year":"2019","unstructured":"Weber SN, Bopp C, Krawczyk M, et al. Genetics of gallstone disease revisited: updated inventory of human lithogenic genes. Curr Opin Gastroenterol. 2019;35(2):82\u20137. https:\/\/doi.org\/10.1097\/MOG.0000000000000511.","journal-title":"Curr Opin Gastroenterol"},{"issue":"6","key":"4161_CR9","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1002\/hep.26563","volume":"58","author":"S Stender","year":"2013","unstructured":"Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Elevated BMI as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study. Hepatology. 2013;58(6):2133\u201341. https:\/\/doi.org\/10.1002\/hep.26563.","journal-title":"Hepatology"},{"key":"4161_CR10","doi-asserted-by":"publisher","first-page":"1189553","DOI":"10.3389\/fendo.2023.1189553","volume":"14","author":"G Zhang","year":"2023","unstructured":"Zhang G, Ding Z, Yang J, et al. Visceral adiposity index and gallstone risk in US adults. Front Endocrinol (Lausanne). 2023;14:1189553. https:\/\/doi.org\/10.3389\/fendo.2023.1189553.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4161_CR11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12876-024-03280-1","volume":"24","author":"C Wei","year":"2024","unstructured":"Wei C, Zhang G. Association between body roundness index (BRI) and gallstones: results of the 2017\u20132020 National health and nutrition examination survey (NHANES). BMC Gastroenterol. 2024;24(1):192. https:\/\/doi.org\/10.1186\/s12876-024-03280-1.","journal-title":"BMC Gastroenterol"},{"key":"4161_CR12","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.2147\/DMSO.S266227","volume":"13","author":"N Kapoor","year":"2020","unstructured":"Kapoor N, Jiwanmall SA, Nandyal MB, et al. METS-VF: A novel obesity indicator. Diabetes Metab Syndr Obes. 2020;13:3261\u20137. https:\/\/doi.org\/10.2147\/DMSO.S266227.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"4161_CR13","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.2147\/DMSO.S418702","volume":"16","author":"C Torun","year":"2023","unstructured":"Torun C, Ankarali H, Castur L, et al. METS-VF vs other adiposity indices. Diabetes Metab Syndr Obes. 2023;16:2605\u201315. https:\/\/doi.org\/10.2147\/DMSO.S418702.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"11","key":"4161_CR14","doi-asserted-by":"publisher","first-page":"e019968","DOI":"10.1161\/JAHA.120.019968","volume":"10","author":"AA Kammerlander","year":"2021","unstructured":"Kammerlander AA, Lyass A, Mahoney TF, et al. Visceral adipose tissue and cardiometabolic risk. J Am Heart Assoc. 2021;10(11):e019968. https:\/\/doi.org\/10.1161\/JAHA.120.019968.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"4161_CR15","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1113\/JP284582","volume":"601","author":"SB Vasamsetti","year":"2023","unstructured":"Vasamsetti SB, Natarajan N, Sadaf S, et al. Visceral adipose-derived metabolic hormones. J Physiol. 2023;601(11):2099\u2013120. https:\/\/doi.org\/10.1113\/JP284582.","journal-title":"J Physiol"},{"key":"4161_CR16","doi-asserted-by":"publisher","unstructured":"Zhang Y, Wang M, Cai X, et al. Associations of noninsulin-based insulin resistance indices with presence and extent of multiterritorial atherosclerosis: a cross-sectional study. J Clin Lipidol. 2025;19(1):60\u201371. https:\/\/doi.org\/10.1016\/j.jacl.2024.09.011","DOI":"10.1016\/j.jacl.2024.09.011"},{"issue":"11","key":"4161_CR17","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3748\/wjg.v11.i11.1653","volume":"11","author":"N Mendez-Sanchez","year":"2005","unstructured":"Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D, et al. Metabolic syndrome and gallstone disease. World J Gastroenterol. 2005;11(11):1653\u20137. https:\/\/doi.org\/10.3748\/wjg.v11.i11.1653.","journal-title":"World J Gastroenterol"},{"key":"4161_CR18","unstructured":"National Center for Health Statistics. National Health and Nutrition Examination Survey: Laboratory Procedures Manual [Internet]. Hyattsville, MD: Centers for Disease Control and Prevention. 2023. [cited 2024 Jul 5]. Available from: https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/"},{"issue":"3","key":"4161_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000471488","volume":"10","author":"GH Goossens","year":"2017","unstructured":"Goossens GH. The metabolic phenotype in obesity. Obes Facts. 2017;10(3):207\u201315. https:\/\/doi.org\/10.1159\/000471488.","journal-title":"Obes Facts"},{"key":"4161_CR20","unstructured":"American Gastroenterological Association. AGA white paper: roadmap for the future of obesity care [Internet]. Bethesda, MD: American Gastroenterological Association. 2021. [cited 2024 Jul 5]. Available from: https:\/\/gastro.org\/"},{"issue":"5","key":"4161_CR21","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.26355\/eurrev_202103_25256","volume":"25","author":"BY Yao","year":"2021","unstructured":"Yao BY, Tian Z, Wu HY, Ma LM. Generative models for predicting chemical composition of gallstones. Eur Rev Med Pharmacol Sci. 2021;25(5):2245\u201351. https:\/\/doi.org\/10.26355\/eurrev_202103_25256.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4161_CR22","doi-asserted-by":"publisher","first-page":"1482003","DOI":"10.3389\/fendo.2024.1482003","volume":"15","author":"H Liu","year":"2024","unstructured":"Liu H, Dong H, Zhou Y, et al. The association between metabolic score for visceral fat and depression in overweight or obese individuals: evidence from NHANES. Front Endocrinol. 2024;15:1482003. https:\/\/doi.org\/10.3389\/fendo.2024.1482003.","journal-title":"Front Endocrinol"},{"issue":"3","key":"4161_CR23","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1002\/fsn3.3889","volume":"12","author":"MS Abdelhamid","year":"2023","unstructured":"Abdelhamid MS, Sherif MH, Abaza HR, et al. Zingiber officinale extract enhances Simvastatin effects in obese rats. Food Sci Nutr. 2023;12(3):1940\u201354. https:\/\/doi.org\/10.1002\/fsn3.3889.","journal-title":"Food Sci Nutr"},{"key":"4161_CR24","doi-asserted-by":"publisher","first-page":"632864","DOI":"10.3389\/fimmu.2021.632864","volume":"12","author":"S Cao","year":"2021","unstructured":"Cao S, Meng X, Li Y, et al. Bile acids elevated in chronic periaortitis could activate farnesoid-X-receptor to suppress IL-6 production by macrophages. Front Immunol. 2021;12:632864. https:\/\/doi.org\/10.3389\/fimmu.2021.632864.","journal-title":"Front Immunol"},{"issue":"9","key":"4161_CR25","doi-asserted-by":"publisher","first-page":"e14029","DOI":"10.1111\/eci.14029","volume":"53","author":"H Abdallah","year":"2023","unstructured":"Abdallah H, Khalil M, Farella I, et al. Ramadan intermittent fasting reduces visceral fat and improves Gastrointestinal motility. Eur J Clin Invest. 2023;53(9):e14029. https:\/\/doi.org\/10.1111\/eci.14029.","journal-title":"Eur J Clin Invest"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04161-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04161-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04161-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T18:03:17Z","timestamp":1754330597000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04161-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4161"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04161-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NHANES study protocols were approved by the National Center for Health Statistics institutional review board, and all participants provided written consent at enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"547"}}